Join an Interview Study Exploring Underrepresented Perspectives on the ELSI of RNA Therapies. 💬 🧬🔬 @d2rmcgill.bsky.social #RNATherapeutics #ELSIResearch #BioethicsResearch #HealthPolicy #EquityDeservingGroups #PrecisionHealth

📧 Outlook may be back online, but we've still got somewhere new for you to scroll. 🎉 D2R is now on Instagram! Follow for event highlights, and the people, stories, and science that make D2R unique. 👋 Come say hello! instagram.com/d2rmcgill

Big week for D2R at #FallingWalls #ScienceSummit26 in Berlin. As part of @mcgill-research.bsky.social's delegation, Dominique Berube & Prof. Claude Bhérer's highlighted how genomics is helping drive the therapies of tomorrow! 🔗Learn more: linkedin.com/feed/update/...

🚨 Cycle 3 of D2R's Translational Impact Research program is live! Up to $3M/project over 3 years for RNA therapeutics research in: Oncology, Rare diseases, Infectious diseases 📅 LOI deadline: Dec 14 🔗 www.mcgill.ca/dna-to-rna/f... @healthsciences.mcgill.ca @mcgillscience.bsky.social

Representing D2R at the Annual Meeting of the Association d'Anémie Falciforme du Québec. Thank you for including us - it was a wonderful opportunity to learn, including from Prof. Loydie Jerome-Majewska. @d2rmcgill.bsky.social anemie-falciforme.org/event/16e-sy...

📣 Calling all D2R trainees! Join us on Nov. 27 for Unwind, featuring trainee presentations on the development and manufacturing of RNA therapeutics, followed by discussion and networking. 🎥 See highlights from the last event below. 👉 mcgill.ca/dna-to-rna/c...

New research co-led by D2R Scholar Diego Loggia used patient-derived miniature heart tissues to uncover biological differences in heart failure. A step toward more personalized therapies, including future #RNA-based treatments. 🔗 mcgill.ca/dna-to-rna/c... @healthsciences.mcgill.ca

✨ #D2RTraineeSpotlight: As a D2R Doctoral Scholar in Prof. Masad Damha’s lab, Michael is developing modified CRISPR RNAs with enhanced stability and therapeutic potential. 👉 mcgill.ca/dna-to-rna/a...

✨ #D2RTraineeSpotlight: Salomé (@usherbrooke.bsky.social) As a D2R Doctoral Scholar in Prof. Karine Choquet lab, Salomé is investigating how #RNA maturation is coordinated during neurogenesis and aging. 👉 Read the full interview: mcgill.ca/dna-to-rna/a...

👩‍🔬 Que se passe-t-il lorsque de jeunes filles visitent un laboratoire de génie biomédical? La curiosité laisse place aux possibilités. 🎥 Regardez ici la visite de jeunes de secondaire 1 à 3 des Les Scientifines au laboratoire de Caroline Wagner, chercheuse financée par D2R.

A new D2R-supported study in the @ajhgnews.bsky.social outlines a new pathway to make personalized RNA therapies more accessible for children with rare neurodevelopmental disorders. Led by Julia Macintosh + Carl Ernst at @theneuro.bsky.social 📖 mcgill.ca/dna-to-rna/c...

⭕ A full-circle moment From D2R trainee, Sébastien This is now building his own lab at @usherbrooke.bsky.social as Assistant Professor in Immunology and Cell Biology! 👉 Read his story: mcgill.ca/dna-to-rna/a...

Interested in the future of AI in healthcare? Join AI for Health 2026 to explore AI-driven advances in RNA therapeutics, biomedical discovery, clinical care, and health policy. 📅 Nov. 30 📍 HEC Montreal 👉 Register by Nov. 23: www.mcgill.ca/dna-to-rna/c... @rimuhc.bsky.social @ivado.bsky.social

Interested in RNA therapeutics and biomanufacturing? Join this interactive workshop exploring the science, technology, and careers driving RNA biomanufacturing. 📅 Nov. 13 | Hybrid 👉 Register: mcgill.ca/dna-to-rna/c...

✨D2R Trainee Spotlight | Diego grows heart cells from patient-derived stem cells to understand why heart disease affects people differently & help advance #RNA based treatments. 🔗https://www.mcgill.ca/dna-to-rna/article/training/trainee-spotlight-diego-loggia

D2R-supported researchers and trainees are advancing innovative breast cancer research, from RNA-based therapies to precision medicine. Meet 4 of the projects driving discovery 👇 🔗 mcgill.ca/dna-to-rna/f... #BreastCancerAwarenessMonth @rimuhc.bsky.social @mcgillgci.bsky.social @ircm.bsky.social

Is a gamechanger in cancer care nearly here? Professor Thomas Duchaine and Dr. Ramy Saleh explain how mRNA cancer vaccines work, when they might become available to the public, and the leading role McGill is playing in this field. Stream "Mark my words": https://linktr.ee/mcgillmarkmywords

🌟 What does it mean to be an #EDI changemaker in a research lab? Join this workshop for trainees to learn how to build a more equitable and inclusive research environment. 📅 In person: Oct. 26 | 3-6 pm www.mcgill.ca/dna-to-rna/c... 💻 Virtual: Nov. 2 | 3-6 pm www.mcgill.ca/dna-to-rna/c...

✨ #D2RTraineeSpotlight: Raïssa From Rwanda to South Korea to Montreal, Raïssa's path to research has spanned the globe. Today, she's developing gene-edited insulin-producing cell spheroids that could help improve treatments for Type 1 diabetes. 👉 www.mcgill.ca/dna-to-rna/a...

🚨 Reminder: only 10 days remain to apply!

D2R | DNA to RNA@d2rmcgill.bsky.social · 2mo ago

🔬 New funding opportunity from D2R: ELSI of Genomics Catalyst Grants Support research examining the ethical, legal, social, policy, and equity dimensions of genomic medicine while building new collaborations across disciplines. 📅 LOI deadline: Oct. 15, 2026 🔗 www.mcgill.ca/dna-to-rna/f...

The best mentors don't just shape careers. They inspire others to mentor. Prof. Yann Joly reflects on Robert Sladek's legacy and how he's carrying those lessons forward through a new mentorship initiative. 🔗 mcgill.ca/dna-to-rna/a... @genomicsandpolicy.bsky.social

A Legacy of Mentorship

When Prof. Yann Joly talks about the late Prof. Robert Sladek, he does not start with genomics, research achievements or scientific breakthroughs. Instead, he talks about conversations. About humour. ...

mcgill.ca

✨ #D2RTraineeSpotlight: Julia Fulber From #RNA therapeutic manufacturing and quality control to strengthening global RNA production capacity, Julia is making an impact across multiple D2R-supported projects while completing her PhD. 👉 mcgill.ca/dna-to-rna/a...

🧡 On the National Day for Truth and Reconciliation, Tamara Hansen, D2R's Associate Director, Indigenous Health Research, reflects on what reconciliation means in research. #ResearchCanBeReconciliation youtube.com/shorts/PhC4k...

National Day for Truth and Reconciliation

YouTube video by D2R | DNA to RNA

youtube.com

🔊 #D2RProjectSpotlight Led by Maria Vera Ugalde (McGill), this project explores antisense oligonucleotides, a novel RNA-based approach to help restore cells' natural defense systems and combat neurodegenerative diseases like ALS and Alzheimers. mcgill.ca/dna-to-rna/f...

✨ #D2RTraineeSpotlight 🧠 Meet Vishvak (McGill), a D2R Scholar and PhD student in #ComputerScience. His research uses #AI to analyze single-cell and spatial #genomics data, helping us better understand how cells develop, change, and respond to therapies. 👉 www.mcgill.ca/dna-to-rna/a...

🔊 #D2RProjectSpotlight Led by Suhad Ali (@rimuhc.bsky.social ) this project is validating a new #RNA-based therapy for triple-negative #breastcancer, an aggressive cancer with limited treatment options. 🔗 mcgill.ca/dna-to-rna/f...

🧡 What does #ResearchCanBeReconciliation mean? We spoke with Indigenous artist Summer (Niibin) Taylor about the inspiration behind this year's D2R design for the National Day for Truth and Reconciliation. 📖 Read the Q&A: www.mcgill.ca/dna-to-rna/a...

🎉 Congratulations to the recipients of the 2026 D2R Scholar Awards! This year, D2R is supporting 30 outstanding Master's and Doctoral students conducting innovative #RNAResearch at @mcgill.ca, @uottawa.ca, UBC, and @usherbrooke.bsky.social. 🔗 www.mcgill.ca/dna-to-rna/c...

🔬 New funding opportunity from D2R: ELSI of Genomics Catalyst Grants Support research examining the ethical, legal, social, policy, and equity dimensions of genomic medicine while building new collaborations across disciplines. 📅 LOI deadline: Oct. 15, 2026 🔗 www.mcgill.ca/dna-to-rna/f...

📢 New funding opportunity The D2R Strategic Initiative on Cancer Vaccines will support multidisciplinary teams advancing neoantigen-based cancer vaccines toward clinical implementation, including first-in-human studies. 📅 LOI deadline: Sept. 1, 2026 (9 a.m. ET) 🔗 www.mcgill.ca/dna-to-rna/f...